Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction

ConditionsInduced; Birth Labor Onset and Length Abnormalities

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-50

SponsorWestern Galilee Hospital-Nahariya

About this trial

This study aims to evaluate the efficacy and safety of combining papaverine with oxytocin for labor induction compared to oxytocin alone

Eligibility criteria

Qualifiers

Women with a singleton pregnancy Over the age of 18 Term (between 37-42 weeks of gestation) A medical decision for labor induction using oxytocin. Cephalic presentation Viable fetus nulliparity

Disqualifiers

parity >1

Twin pregnancy Women with a previous cesarean section Severe fetal anomalies Women with psychiatric disorders, including depression and schizophrenia. Contraindication to vaginal delivery Women unable to sign the consent form Women known to have SVT (supraventricular tachycardia). Women with a heart rate over 100 or arrhythmia Known sensitivity to any component of the drug Liver disease

Trial design

Treatments tested in this trial

Papaverine
normal saline

Treatment groups

126 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Western Galilee Hospital-Nahariya

Lead sponsor

Source ClinicalTrials.gov